1989
DOI: 10.1007/bf02716683
|View full text |Cite
|
Sign up to set email alerts
|

Induction of hepatic drug metabolizing enzymes by DL-methionine in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1991
1991
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…Specific dietary amino acids also have specific inductive effects on the mixed-function oxidase system, and tryptophan has been claimed to be unique among amino acids in that it increases hepatic protein synthesis, cytochrome P-450 content and various cytochrome P-450-mediated oxygenase activities (Everts and Mostafa 1981), although more recently i.p. injection of DL-methionine to rats has been shown similarly to induce cytochromes P-450 and bs, P-450 reductase, UDPGA-transferase and aminopyrine demethylase activity (Kamat et al 1989). "Albino rats were fed 28 days from weaning on the low protein diet (3-5% casein) or on the normal protein diet (26%).…”
Section: Protein and Sulphur Amino Acidsmentioning
confidence: 96%
“…Specific dietary amino acids also have specific inductive effects on the mixed-function oxidase system, and tryptophan has been claimed to be unique among amino acids in that it increases hepatic protein synthesis, cytochrome P-450 content and various cytochrome P-450-mediated oxygenase activities (Everts and Mostafa 1981), although more recently i.p. injection of DL-methionine to rats has been shown similarly to induce cytochromes P-450 and bs, P-450 reductase, UDPGA-transferase and aminopyrine demethylase activity (Kamat et al 1989). "Albino rats were fed 28 days from weaning on the low protein diet (3-5% casein) or on the normal protein diet (26%).…”
Section: Protein and Sulphur Amino Acidsmentioning
confidence: 96%
“…The results showed that with the drug-loading vehicles, EPO can stay in vivo longer and in this way the therapy effect of EPO will be enhanced definitely. Metabolism of EPO has been proved that in the kidney, liver, heart and neural tissue [18]. Fig.…”
Section: Epo Cures and Metabolize Of Epo Nanoparticles In Vivomentioning
confidence: 99%
“…After 313h the concentration dropped down as show in the curve. The releasing curve can be attributed to two factors: first, the degradation of nanoparticles was the reason for instantaneous increase of spectrum; second, slow penetration of PBS into the shell brought a slowly change in cross-linking density of the polyelectrolyte complexes, leading to a slow releasing of EPO after the abrupt increase of the signal [15][16][17].…”
Section: Epo-loading Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…It also acts as a lipotropic agent and prevents excess fat build-up in the liver. Low levels of Methionine are known to cause temporary folic acid deficiency by trapping the folate in the liver (Brosnan et al, 2006;Kamat et al, 1989). Antioxidant Vitamins [A,C,E] and Methylsulfonylmethane that support phase I and phase II activities also serve as hepatoprotective agents.…”
Section: Introductionmentioning
confidence: 99%